Dr. Patrick Soon-Shiong
speaker
969 appearances
7 recordings
4 series
first heard Nov 2024
last heard 9 Oct
Dr. Patrick Soon-Shiong’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Oct 2025 with 1.
Appearances
You have in the package insert the mechanism of action.
It's the only drug in the history of medicine, which is basically your natural protein.
in which you have a foamed, it stimulates your natural killer cells and T cells and memory T cells.
You've proved this for bladder cancer where you have, now it's technical, CIS, which is called carcinoma in situ, with or without papillary.
It's approved.
We have now patients live 10 years.
We have patients who have not lost their bladder, for which if you remove the bladder, it's a 9%, 8% mortality from the surgery alone.
And if you have no bladder, your quality of life, think about your quality of life, and you get sepsis at 30%.
Okay, so now we have another indication in bladder.
We have papary without cysts, which I've done in another 100 patients.
It's the same approval.
All you want is an addition to that.
After all the trial, refused to file.
I said, explain this to me.
Why do you refuse to look at this?
And they couldn't give me a reason.
So then out of desperation, I'll just share with you now, because I openly have to do this.
I know this is a risk to myself and the organization, but I have to do this because I have to explain or answer the question of why.
So I said to these two reviewers, senior reviewers, one a female and one a male, they've been here for years and years,
If my father had bladder cancer, and I knew I had a molecule that is safe, it's already approved, and I could preserve the patient's bladder, my father's bladder, for more than three years and ongoing without chemotherapy, why wouldn't I give my father that chance?
Showing 361–380 of 969 · page 19 of 49
← Previous
Next →